Anti-CD38 monoclonal antibody (daratumumab biosimilar)

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMA1004-100uL

  • Size

    100uL

  • Price

    $320

1
Daratumumab (brand name Darzalex) is a first-in-class humanized IgG1k monoclonal antibody that targets the CD38 epitope. It was developed by Janssen Biotech and Genmab. The drug was approved in 2015 by FDA for treatment of multiple myeloma.
target CD38
gene id 952
alias CD38, T10, ADPRC1
reactivity Human
host Human
clonality Monoclonal
clone number HuMax-CD38
iso type IgG1
formulation Purified from cell culture supernatant by affinity chromatography; Kept in PBS (pH 7.4) with 0.1% BSA, 0.1% ProClin 300 and 50% Glycerol
applications ELISA, Flow Cytometry
dilution ELISA 1:4000
shipping With ice packs
storage Store at -20°C for at least 1 year. Avoid multiple freeze-thaw cycles.

PRODUCT

  • SKU

    DMA1004-100uL

  • Size

    100uL

  • Price

    $320

1